alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › aria-h

aria-h

4 studies tagged aria-h, dated 2026-01-01 to 2026-08-31. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. SWI versus T2*GRE for ARIA-H monitoring: a pragmatic perspective on adoption in clinical practice 2026-08-31
  2. Deep learning-based detection of cerebral microbleeds on 2D T2*-weighted GRE MRI: toward ARIA-H risk assessment in Alzheimer's treatment 2026-03-23
  3. Six-month follow-up of ARIA-H and iron deposition in real-world lecanemab therapy for Alzheimer's disease: Evidence from a Chinese 7T MRI cohort 2026-01-01

Studies

4 studies carry this tag.

Date range

2026

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Current neuropharmacology 1
  • Frontiers in aging neuroscience 1
  • Neuroradiology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. SWI versus T2*GRE for ARIA-H monitoring: a pragmatic perspective on adoption in clinical practice

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neuroradiology 2026-08-31 Treatments

    Although radiological severity thresholds for amyloid-related imaging abnormalities with hemosiderin deposition (ARIA-H) were developed using 2-dimensional acquisitions of T2*-weighted gradient-recalled echo (T2*GRE) MRI in pivotal anti-amyloid trials, adoption of well established 3D susceptibility-weighted imaging (SWI) in ARIA-H monitoring in clinical practice represents a reasonable long-term direction for clinical practice.

  2. Deep learning-based detection of cerebral microbleeds on 2D T2*-weighted GRE MRI: toward ARIA-H risk assessment in Alzheimer's treatment

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Frontiers in aging neuroscience 2026-03-23 Treatments

    This study demonstrates the feasibility of robust CMB detection using only 2D T2*-weighted GRE MRI.

  3. Six-month follow-up of ARIA-H and iron deposition in real-world lecanemab therapy for Alzheimer's disease: Evidence from a Chinese 7T MRI cohort

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2026-01-01 Treatments

    7T MRI provides superior ARIA-H detection and iron dynamics monitoring, supporting its role in risk stratification and therapy assessment for lecanemab-treated patients.

  4. Structural and Functional Determinants of ARIA-H Risk in Anti-Amyloid Monoclonal Antibodies: A Comparative Mechanistic Framework for Alzheimer's Immunotherapy Development

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Current neuropharmacology 2026-01-01 Treatments

    We identify a risk hierarchy for ARIA-H among anti-Aβ mAbs and link specific mAb biophysical properties-Aβ binding type, affinity for soluble oligomers, epitope specificity, Fc structure, and plaque clearance dynamics-directly to ARIA-H pathogenesis.

All topic tags with their study counts